Search results
Xencor (NASDAQ:XNCR) Price Target Cut to $40.00 by Analysts at Raymond James
ETF DAILY NEWS· 4 days agoXencor (NASDAQ:XNCR – Free Report) had its target price lowered by Raymond James from $58.00 to $40.00 in a research report report published on Friday, Benzinga reports. The firm currently has ...
A new look at why old age is linked to severe, even fatal COVID
Medical Xpress· 4 days agoEver since the beginning of the pandemic in 2020, it has been abundantly clear that older adults are...
Bird Flu Pandemic Just “A Question Of When”, Says Ex-CDC Director
IFLScience· 2 days agoA former director of the Centers for Disease Control and Prevention (CDC) told a US cable news...
Pentagon ran secret anti-vax campaign against China at height of COVID pandemic
The Raw Story· 4 days agoAccording...perceived as China's growing influence in the Philippines," a country that was ravaged...
We Won't Solve Long COVID Until We Decide What It Is
Medscape· 1 day agoIs a slow recovery from COVID-19 the lingering effects of a bad infection or the start of a new syndrome?
What causes long COVID? Case builds for rogue antibodies
Nature· 6 days agoStudy finds that antibodies from people with the debilitating condition trigger similar symptoms in...
Bayesian Capital Management LP Invests $4.79 Million in Hologic, Inc. (NASDAQ:HOLX)
ETF DAILY NEWS· 6 days agoBayesian Capital Management LP purchased a new position in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) in the 4th quarter, according to the company in its most recent filing with the ...
Xencor (NASDAQ:XNCR) Price Target Cut to $32.00
ETF DAILY NEWS· 3 days agoXencor (NASDAQ:XNCR – Get Free Report) had its target price lowered by BMO Capital Markets from $34.00 to $32.00 in a report issued on Friday, Benzinga reports. The brokerage presently has an ...